CJMY
Subang Jaya Medical Centre (SJMC) celebrates 40 years by pioneering precision medicine, notably aiding Roziah’s battle with Stage 4 lung cancer since 2014.
Advanced genetic testing tailored her treatment, offering renewed hope.
This milestone positions SJMC as a leader in oncology, blending innovation with compassion.
For patients and families seeking effective care, its genomic profiling signals a transformative approach to cancer treatment.
SJMC delivers hope
SJMC introduced molecular genetics in 2018, using Next-Generation Sequencing (NGS).
Prof Dr Pathmanathan Rajadurai, Consultant Pathologist, said, “It helps us treat cancer precisely, giving patients real hope.”
The centre published Malaysia’s first NGS lung cancer data, shaping local oncology. “SJMC precision care” targets mutations, improving outcomes.
Also, Roziah’s journey inspires. Diagnosed in 2014, she thrived on targeted therapy, defying odds with support from her husband.
Next, radiosurgery tackled her brain tumours. A 20-minute session with real-time imaging stopped growth, enhancing her quality of life.
Finally, liquid biopsies offer non-invasive testing.
Pathmanathan noted, “It provides quicker, safer genomic insights for patients.”
SJMC leads oncology
SJMC’s NGS reveals local trends. High EGFR mutations in lung cancer respond to targeted therapies, aligning with global studies.
The centre expands precision medicine beyond cancer. Cardiology and AI integration promise broader impact. “SJMC genomic revolution” advances care.
Also, challenges persist. Cost and awareness hinder access, but SJMC collaborates with partners to expand coverage.
Then, its legacy grows. Celebrating 40 years, it earned the World Cancer Day award for lung care innovation.
Background shows evolution. From traditional treatments, SJMC now pioneers personalised care, driven by research.
SJMC’s 40-year milestone redefines cancer care. Its “SJMC genomic revolution” offers hope.
Visit https://subangjayamedicalcentre.com/ for details.
Admin
Add comment